Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Sale |
2024-09-30 | 13G | Cabaletta Bio, Inc. CABA |
Venrock Healthcare Capital Partners III, L.P. | 1,590,696 3.300% |
-973,256 (-37.96%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Century Therapeutics, Inc. IPSC |
Venrock Healthcare Capital Partners III, L.P. | 5,389,259 6.400% |
1,984,126 (+58.27%) |
Filing History |
| 2024-11-14 5:46 pm Sale |
2024-09-30 | 13G | Celcuity Inc. CELC |
Venrock Healthcare Capital Partners III, L.P. | 0 0.000% |
-2,476,980 (Position Closed) |
Filing History |
| 2024-11-14 5:45 pm Purchase |
2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS |
Venrock Healthcare Capital Partners III, L.P. | 3,458,645 6.100% |
232,839 (+7.22%) |
Filing History |
| 2024-08-19 4:15 pm Purchase |
2024-08-08 | 13G | Tenax Therapeutics, Inc. TENX |
Venrock Healthcare Capital Partners III, L.P. | 355,224 9.990% |
355,224 (New Position) |
Filing History |
| 2024-08-01 4:18 pm Purchase |
2024-07-22 | 13G | Artiva Biotherapeutics, Inc. ARTV |
Venrock Healthcare Capital Partners III, L.P. | 1,609,569 6.900% |
1,609,569 (New Position) |
Filing History |
| 2024-07-25 8:48 pm Purchase |
2024-07-15 | 13G | CASI Pharmaceuticals, Inc. CASI |
Venrock Healthcare Capital Partners III, L.P. | 1,507,040 9.990% |
1,507,040 (New Position) |
Filing History |
| 2024-06-24 4:15 pm Purchase |
2024-06-13 | 13G | Perceptive Capital Solutions Corp Class A Ordinary Shares PCSC |
Venrock Healthcare Capital Partners III, L.P. | 750,000 8.400% |
750,000 (New Position) |
Filing History |
| 2024-05-31 4:18 pm Purchase |
2024-05-21 | 13G | Erasca, Inc. ERAS |
Venrock Healthcare Capital Partners III, L.P. | 16,216,216 6.500% |
16,216,216 (New Position) |
Filing History |
| 2024-05-02 4:16 pm Purchase |
2024-04-22 | 13G | Zura Bio Limited ZURA |
Venrock Healthcare Capital Partners III, L.P. | 6,399,619 9.990% |
6,399,619 (New Position) |
Filing History |
| 2024-04-29 7:28 pm Purchase |
2024-04-17 | 13G | ARCA biopharma, Inc. ABIO |
Venrock Healthcare Capital Partners III, L.P. | 62,889 5.200% |
62,889 (New Position) |
Filing History |
| 2024-04-01 6:21 pm Purchase |
2024-03-22 | 13G | Aquestive Therapeutics, Inc. AQST |
Venrock Healthcare Capital Partners III, L.P. | 5,555,555 6.500% |
5,555,555 (New Position) |
Filing History |
| 2024-03-04 4:16 pm Purchase |
2024-02-21 | 13G | Century Therapeutics, Inc. IPSC |
Venrock Healthcare Capital Partners III, L.P. | 3,405,133 5.400% |
3,405,133 (New Position) |
Filing History |
| 2024-02-26 4:15 pm Purchase |
2024-02-16 | 13G | enGene Holdings Inc. Common Stock ENGN |
Venrock Healthcare Capital Partners III, L.P. | 2,565,841 5.900% |
2,565,841 (New Position) |
Filing History |
| 2024-02-14 9:20 pm Purchase |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Venrock Healthcare Capital Partners III, L.P. | 7,877,817 9.990% |
2,080,232 (+35.88%) |
Filing History |
| 2024-02-14 9:13 pm Unchanged |
2023-12-31 | 13G | Avalo Therapeutics, Inc. AVTX |
Venrock Healthcare Capital Partners III, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 8:56 pm Purchase |
2023-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
Venrock Healthcare Capital Partners III, L.P. | 11,328,000 9.400% |
1,650,000 (+17.05%) |
Filing History |
| 2024-02-14 8:56 pm Sale |
2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Venrock Healthcare Capital Partners III, L.P. | 925,048 2.800% |
-1,283,764 (-58.12%) |
Filing History |
| 2024-02-14 8:53 pm Purchase |
2023-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Venrock Healthcare Capital Partners III, L.P. | 2,563,952 6.400% |
668,667 (+35.28%) |
Filing History |
| 2024-02-14 8:53 pm Purchase |
2023-12-31 | 13G | Enliven Therapeutics, Inc. ELVN |
Venrock Healthcare Capital Partners III, L.P. | 2,954,902 7.200% |
740,760 (+33.46%) |
Filing History |